Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Cathy Burton"'
Autor:
Eve Roman, Debra Howell, Alexandra Smith, Simon Crouch, Timothy Bagguley, Daniel Painter, Rebecca Sheridan, Dorothy McCaughan, John Blase, William Curson, Han-I Wang, Andrea Manca, Alastair Bennett, Vijay S Gc, Carol Miller, Karl Atkin, Richard Thomson, Barbara Hanratty, Cathy Burton, John Ashcroft, Russell Patmore
Publikováno v:
Programme Grants for Applied Research, Vol 12, Iss 05 (2024)
Background Arising in blood and lymph-forming tissues, haematological malignancies (leukaemias, lymphomas and myelomas) are the fifth most common group of cancers. Around 60% are currently incurable and follow a chronic, remitting–relapsing pathway
Externí odkaz:
https://doaj.org/article/a4fe7f20bbf6466f9159312c7525884a
Autor:
Matthew Holmes, Gina B. Scott, Samuel Heaton, Tyler Barr, Basem Askar, Louise M.E. Müller, Victoria A. Jennings, Christy Ralph, Cathy Burton, Alan Melcher, Peter Hillmen, Christopher Parrish, Fiona Errington-Mais
Publikováno v:
Molecular Therapy: Oncolytics, Vol 29, Iss , Pp 17-29 (2023)
Primary drug resistance and minimal residual disease are major challenges in the treatment of B cell neoplasms. Therefore, this study aimed to identify a novel treatment capable of eradicating malignant B cells and drug-resistant disease. Oncolytic v
Externí odkaz:
https://doaj.org/article/5203c050e9894f55a9405ad6fce9ab42
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 21, Iss , Pp 66-68 (2020)
Histiocytic sarcoma (HS) is an exceedingly rare and aggressive neoplasm of lymphoid and haematopoietic tissues and expresses histological and phenotypical characteristics of mature histiocytes. There have only been a few cases of documented HS in the
Externí odkaz:
https://doaj.org/article/d026d9e944534f4aa404ad138444e7c4
Autor:
Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy, Fay Chinnery, Laura Day, Diana Fernando, Kirit Ardeshna, Graham Collins, John Radford, Simon Rule, Andrew McMillan, Peter Johnson, Gareth Griffiths
Publikováno v:
F1000Research, Vol 9 (2020)
Background: Over 13,000 new cases of non-Hodgkin’s lymphoma (NHL) are diagnosed in the UK, with approximately 4,900 attributable deaths each year. Diffuse Large B-cell Lymphoma (DLBCL) is the most common NHL comprising one third of adult NHL cases.
Externí odkaz:
https://doaj.org/article/db65a63ed78441e69e7645344810acd2
Autor:
Maxine JE Lamb, Eve Roman, Debra A Howell, Eleanor Kane, Timothy Bagguley, Cathy Burton, Russell Patmore, Alexandra G Smith
Publikováno v:
BJGP Open, Vol 3, Iss 4 (2019)
Background: Hodgkin lymphoma is usually detected in primary care with early signs and symptoms, and is highly treatable with standardised chemotherapy. However, late presentation is associated with poorer outcomes. Aim: To investigate the relationshi
Externí odkaz:
https://doaj.org/article/c2ae04807f7a4ca8b38e5a6aefc36f9c
Publikováno v:
Case Reports in Genetics, Vol 2019 (2019)
We report a case of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) occurring in a 53-year-old female with Li Fraumeni syndrome (LFS) with a prior history of breast cancer. We present the clinical features, investigation, and mana
Externí odkaz:
https://doaj.org/article/7bc8e85421c2441f8c50ca7fc389cfa2
Autor:
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, Brendan Hodkinson, Emil Kumar, Thomas Cummin, Margaret Ashton-Key, Sharon Barrans, Suzan van Hoppe, Cathy Burton, Mohamed Elshiekh, Simon Rule, Nicola Crosbie, Andrew Clear, Maria Calaminici, Hendrik Runge, Robert K. Hills, David W. Scott, Lisa M. Rimsza, Geetha Menon, Chulin Sha, John R. Davies, Ai Nagano, Andrew Davies, Daniel Painter, Alexandra Smith, John Gribben, Kikkeri N. Naresh, David R. Westhead, Jessica Okosun, Andrew Steele, Daniel J. Hodson, Sriram Balasubramanian, Peter Johnson, Jun Wang, Jude Fitzgibbon
Publikováno v:
Blood Advances. 7:845-855
Despite the effectiveness of immuno-chemotherapy, 40% of patients with diffuse large B-cell lymphoma (DLBCL) experience relapse or refractory disease. Longitudinal studies have previously focused on the mutational landscape of relapse but fell short
Autor:
Simon Crouch, Daniel Painter, Sharon L. Barrans, Eve Roman, Philip A. Beer, Susanna L. Cooke, Paul Glover, Suzan J.L. Van Hoppe, Nichola Webster, Stuart E. Lacy, Camilo Ruiz, Peter J. Campbell, Daniel J. Hodson, Russell Patmore, Cathy Burton, Alexandra Smith, Reuben M. Tooze
Publikováno v:
Blood Advances. 6:5716-5731
Follicular lymphoma (FL) is morphologically and clinically diverse, with mutations in epigenetic regulators alongside t(14;18) identified as disease-initiating events. Identification of additional mutational entities confirms this cancer’s heteroge
Autor:
Andrew J Davies, Louise Stanton, Josh Caddy, Sharon Barrans, Sam Wilding, Geoff N Saunders, Christoph Mamot, Urban Novak, Andrew K. McMillan, Paul A Fields, Graham P. Collins, Richard Stephens, Francesco Cucco, Chulin Sha, Moniek Van Hoppe, Reuben M Tooze, Matthew A Care, Gareth Griffiths, Anna Schuh, Ming-Qing Du, David R Westhead, Cathy Burton, Peter Johnson
Publikováno v:
Blood. 140:1770-1772
Autor:
Russell Frood, Matt Clark, Cathy Burton, Charalampos Tsoumpas, Alejandro F. Frangi, Fergus Gleeson, Chirag Patel, Andrew Scarsbrook
Objectives Relapse occurs in ~20% of patients with classical Hodgkin lymphoma (cHL) despite treatment adaption based on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography response. The objective was to evaluate pre-treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad2810f976bd0f461d78c687b534e86
https://eprints.whiterose.ac.uk/190732/6/s00330-022-09039-0.pdf
https://eprints.whiterose.ac.uk/190732/6/s00330-022-09039-0.pdf